drugset / Trial / NCT06086886
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of BMS-986454 in healthy adult participants.
Timeline
- Start
- 2023-11-16
- Primary completion
- 2024-12-20
- Completion
- 2024-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986454 | Unknown | — | — |
Indications
No indication recorded.